Claims for Patent: 6,620,609

Summary for Patent: 6,620,609

Title:	Process of microwave sterilization of culture media for selection of recombinant microorganisms
Abstract:	The invention relates to a process for a simplified and rapid preparation of sterile culture media using microwave ovens. The sterile media of the invention are usable for the selection and identification of microorganisms transformed by viral or plasmid DNA.
Inventor(s):	Armau; Elise (Toulouse, FR), Tiraby; Gerard (Toulouse, FR)
Assignee:	Cayla (Toulouse, FR)
Application Number:	09/352,942
Patent Claims:	1. A process of using microwave sterilization for the preparation of a sterile culture medium for the selection of recombinant microorganisms using the action of microwaves, said process consisting of the steps of: a. adding a selection agent and/or identification agent, and further adding a heat protective agent, to a suitable culture medium containing suitable culturing ingredients, wherein said adding step is carried out prior to microwave sterilization; b. mixing all said culturing ingredients in said suitable culture medium with said selection and/or identification agent, and heat protective agent, said culturing ingredients and said selection and/or identification agent and heat protective agent being in powder form, so as to obtain a mixture in powder form; c. mixing said mixture in powder form with a sufficient quantity of water to obtain a suspension of said powder in water; and d. subjecting said suspension of powder dissolved in water to heat by the action of microwaves in order to sterilize said suspension without raising pressure above ambient pressure by not raising temperature of said suspension above its boiling temperature and allow said suspension to become homogeneous. 2. A process according to claim 1, wherein said water is sterile and the mixture in powder form is sterilized by gamma irradiation before mixing the powder with said sterile water. 3. A process according to claim 1, wherein the selection agent added in step a, comprises an antibiotic selected from the group consisting of penicillin, aminosides, tetracycline, chloramphenicol and zeocin. 4. A process according to claim 3, wherein the culture medium is designed for gram negative bacteria and at least one antibiotic added in step a is specific to gram positive bacteria. 5. A process according to claim 4, wherein the gram negative bacteria are from the species Escherichia coli. 6. A process according to claim 3, wherein the culture medium is designed for eukaryotic microorganisms and at least one antibiotic added in step a has a large spectrum antibacterial activity. 7. A process according to claim 6 wherein the eukaryotic microorganisms are yeasts. 8. A process according to claim 1, wherein the identification agent added in step a comprises a chromogenic or fluorescent molecule. 9. A process according to claim 1, wherein an induction agent is further added during step a. 10. A process according to claim 9, wherein the induction agent added in step a comprises isopropyl-.beta.-D-Thiogalactopyranoside (IPTG). 11. A process according to claim 1, wherein a molecule having antifungal activity is further added during step a. 12. A process according to claim 1, wherein the heat protective agent is selected from the group consisting of saccharose, trehalose, amylopectins, starches, mannitol and sorbitol. 13. A process according to claim 1, wherein said heat by the action of microwaves is provided by a microwave oven.

Details for Patent 6,620,609

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2018-07-15